What is the Jagsonpal Pharmaceuticals Ltd share price today?

The share price of NSE:JAGSNPHARM-EQ on 01 Oct 2026 (as of 15:03:55 IST) is ₹231.32.

What is the NSE:JAGSNPHARM-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:JAGSNPHARM-EQ 52 week high low range shows a high of ₹264.5 and a low of ₹155.

What is the Jagsonpal Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Jagsonpal Pharmaceuticals Ltd market cap is ₹15638500000.

What is the shareholding pattern of Jagsonpal Pharmaceuticals Ltd Stock?

The shareholding pattern of Jagsonpal Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 69.05% Foreign Institutional Investors (FII): 2.3% Domestic Institutional Investors (DII): 0.62% Mutual Funds: 0% Retail & Others: 28.03% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Jagsonpal Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Jagsonpal Pharmaceuticals Ltd is 34.3885, and the Price-to-Book (PB) ratio is 4.828, as on 01 Oct 2026.

Jagsonpal Pharmaceuticals Share Price

216.21-0.12 (-0.06%)

-2.98% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.06%

1 Week

-2.58%

1 Month

-6.70%

3 Month

-9.77%

6 Month

+1.02%

YTD

+12.25%

1 Year

-2.98%

5 Year

+204.35%

10 Year

+1231.34%

Max

+3549.73%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

215.01

212.58

203.41

194.61

155.00

High

219.90

226.64

243.46

251.00

264.50

About

Jagsonpal Pharmaceutical is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities. Founded in 1964 the company specializes in developing and manufacturing Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

JAGSNPHARMNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

217-4.94 (-2.23%)

212.58

226.64

1,425Cr

Jagsonpal Pharmaceuticals Share Price

216.21-0.12 (-0.06%)

-2.98% past 1 Year

Open a free Demat account in minutes to start investing and screening .

Jagsonpal Pharmaceuticals Share Price

216.21-0.12 (-0.06%)

-2.98% past 1 Year

Financial overview

Compounded Sales Growth

10 years7%

5 years9%

3 years7%

Last year7%

Compounded Profit Growth

10 years29%

5 years20%

3 years17%

Last year-22%

Stock Price CAGR

10 years30%

5 years25%

3 years10%

1 year-5%

Return on Equity

10 years13%

5 years19%

3 years20%

Last year18%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
7%	9%	7%	7%
29%	20%	17%	-22%
30%	25%	10%	-5%
13%	19%	20%	18%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

JAGSNPHARM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
217	₹1425 Cr	31.32	1.89	8.18	₹43 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026
₹96 Cr
₹2 Cr
₹99 Cr
₹82 Cr
₹19 Cr
₹29 L
₹16 Cr
₹12 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006	Mar 2005
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr
₹20 Cr	₹22 Cr	₹17 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹242 Cr	₹205 Cr	₹157 Cr	₹137 Cr	₹120 Cr	₹109 Cr	₹98 Cr	₹91 Cr	₹85 Cr	₹97 Cr	₹85 Cr	₹82 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹80 Cr	₹74 Cr	₹67 Cr	₹62 Cr	₹59 Cr	₹57 Cr	₹55 Cr
₹242 Cr	₹205 Cr	₹157 Cr	₹137 Cr	₹120 Cr	₹101 Cr	₹90 Cr	₹84 Cr	₹77 Cr	₹89 Cr	₹77 Cr	₹74 Cr	₹73 Cr	₹72 Cr	₹72 Cr	₹66 Cr	₹60 Cr	₹53 Cr	₹47 Cr	₹45 Cr	₹42 Cr	₹40 Cr
₹0	₹0	₹0	₹0	₹0	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr
₹276 Cr	₹240 Cr	₹187 Cr	₹159 Cr	₹133 Cr	₹122 Cr	₹111 Cr	₹104 Cr	₹98 Cr	₹110 Cr	₹98 Cr	₹95 Cr	₹99 Cr	₹98 Cr	₹98 Cr	₹93 Cr	₹88 Cr	₹80 Cr	₹75 Cr	₹72 Cr	₹70 Cr	₹68 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹16 Cr	₹25 Cr	₹36 Cr	₹44 Cr	₹35 Cr	₹30 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹32 L	₹27 L	₹26 L	₹5 Cr	₹3 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹7 Cr
₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹7 Cr	₹8 Cr	₹8 Cr	₹5 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1 Cr	₹1 Cr	₹8 Cr	₹1 Cr	₹1 Cr	₹2 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹12 Cr	₹12 Cr	₹18 Cr	₹8 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹23 Cr	₹31 Cr	₹43 Cr	₹52 Cr	₹45 Cr	₹39 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹12 Cr	₹10 Cr	₹8 Cr	₹17 Cr	₹19 Cr	₹18 Cr	₹12 Cr	₹12 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹8 Cr	₹5 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹9 Cr	₹11 Cr	₹10 Cr
₹15 Cr	₹15 Cr	₹11 Cr	₹11 Cr	₹8 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹7 Cr	₹5 Cr
₹0	₹0	₹0	₹0	₹0	₹7 Cr	₹6 Cr	₹4 Cr	₹8 Cr	₹8 Cr	₹38 Cr	₹39 Cr	₹36 Cr	₹33 Cr	₹35 Cr	₹28 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹14 Cr	₹1 Cr	₹75 L	₹8 Cr	₹8 Cr	₹5 Cr	₹8 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹4 Cr	₹2 Cr	₹4 Cr	₹6 Cr	₹10 Cr	₹8 Cr	₹13 Cr
₹41 Cr	₹26 Cr	₹19 Cr	₹35 Cr	₹34 Cr	₹40 Cr	₹35 Cr	₹28 Cr	₹29 Cr	₹29 Cr	₹57 Cr	₹55 Cr	₹54 Cr	₹50 Cr	₹53 Cr	₹40 Cr	₹12 Cr	₹12 Cr	₹16 Cr	₹23 Cr	₹27 Cr	₹28 Cr
₹329 Cr	₹278 Cr	₹225 Cr	₹203 Cr	₹171 Cr	₹164 Cr	₹149 Cr	₹136 Cr	₹130 Cr	₹143 Cr	₹159 Cr	₹154 Cr	₹156 Cr	₹153 Cr	₹156 Cr	₹137 Cr	₹123 Cr	₹123 Cr	₹134 Cr	₹147 Cr	₹142 Cr	₹135 Cr
₹22 Cr	₹16 Cr	₹11 Cr	₹6 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹69 L	₹2 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹0	₹0	₹0	₹4 L	₹10 L	₹9 L	₹3 L	₹3 L	₹3 L
₹0	₹0	₹0	₹0	₹0	₹7 Cr	₹6 Cr	₹4 Cr	₹8 Cr	₹8 Cr	₹38 Cr	₹39 Cr	₹36 Cr	₹33 Cr	₹35 Cr	₹29 Cr	₹20 Cr	₹28 Cr	₹40 Cr	₹49 Cr	₹42 Cr	₹37 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹102 Cr	₹103 Cr	₹12 Cr	₹33 Cr	₹58 Cr	₹60 Cr	₹58 Cr	₹55 Cr	₹54 Cr	₹53 Cr	₹90 Cr	₹88 Cr	₹87 Cr	₹86 Cr	₹83 Cr	₹79 Cr	₹72 Cr	₹45 Cr	₹44 Cr	₹44 Cr	₹43 Cr	₹41 Cr
₹17 Cr	₹9 Cr	₹2 Cr	₹9 Cr	₹36 Cr	₹34 Cr	₹34 Cr	₹33 Cr	₹32 Cr	₹31 Cr	₹39 Cr	₹36 Cr	₹31 Cr	₹27 Cr	₹24 Cr	₹21 Cr	₹19 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹9 Cr
₹85 Cr	₹94 Cr	₹9 Cr	₹24 Cr	₹23 Cr	₹26 Cr	₹24 Cr	₹22 Cr	₹21 Cr	₹22 Cr	₹52 Cr	₹52 Cr	₹56 Cr	₹58 Cr	₹59 Cr	₹58 Cr	₹53 Cr	₹29 Cr	₹29 Cr	₹31 Cr	₹32 Cr	₹32 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹98 L	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹93 L	₹0	₹0	₹25 Cr	₹17 Cr	₹13 Cr	₹5 Cr	₹0
₹0	₹0	₹0	₹1 Cr	₹29 Cr	₹12 Cr	₹11 Cr	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031
₹0	₹0	₹0	₹1 Cr	₹29 Cr	₹12 Cr	₹11 Cr	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031
₹3 Cr	₹4 Cr	₹12 Cr	₹69 L	₹1 Cr	₹6 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹11 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹85 Cr	₹19 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹29 L	₹13 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹174 Cr	₹117 Cr	₹28 Cr	₹30 Cr	₹55 Cr	₹44 Cr	₹52 Cr	₹38 Cr	₹35 Cr	₹32 Cr	₹58 Cr	₹58 Cr	₹65 Cr	₹66 Cr	₹65 Cr	₹61 Cr	₹53 Cr	₹53 Cr	₹47 Cr	₹44 Cr	₹37 Cr	₹32 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹22 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹15 Cr	₹15 Cr	₹15 Cr	₹21 Cr	₹30 Cr	₹30 Cr	₹29 Cr	₹33 Cr	₹51 Cr	₹48 Cr	₹40 Cr	₹33 Cr	₹31 Cr	₹30 Cr	₹35 Cr	₹23 Cr	₹22 Cr	₹22 Cr	₹34 Cr	₹44 Cr	₹54 Cr	₹67 Cr
₹17 Cr	₹13 Cr	₹11 Cr	₹21 Cr	₹16 Cr	₹13 Cr	₹21 Cr	₹21 Cr	₹25 Cr	₹39 Cr	₹42 Cr	₹45 Cr	₹45 Cr	₹42 Cr	₹42 Cr	₹43 Cr	₹38 Cr	₹37 Cr	₹41 Cr	₹46 Cr	₹37 Cr	₹20 Cr
₹106 Cr	₹129 Cr	₹148 Cr	₹115 Cr	₹25 Cr	₹60 Cr	₹40 Cr	₹39 Cr	₹15 Cr	₹20 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹7 Cr	₹6 Cr	₹7 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹2 Cr
₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹27 L	₹52 L	₹94 L	₹24 L	₹23 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹16 Cr	₹2 Cr	₹4 Cr	₹15 Cr	₹22 Cr	₹14 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹6 Cr	₹10 Cr	₹10 Cr	₹13 Cr
₹156 Cr	₹161 Cr	₹180 Cr	₹172 Cr	₹116 Cr	₹120 Cr	₹96 Cr	₹98 Cr	₹95 Cr	₹110 Cr	₹101 Cr	₹96 Cr	₹91 Cr	₹87 Cr	₹91 Cr	₹76 Cr	₹70 Cr	₹69 Cr	₹87 Cr	₹104 Cr	₹105 Cr	₹103 Cr
₹115 Cr	₹135 Cr	₹160 Cr	₹137 Cr	₹82 Cr	₹80 Cr	₹62 Cr	₹69 Cr	₹66 Cr	₹81 Cr	₹44 Cr	₹41 Cr	₹38 Cr	₹36 Cr	₹38 Cr	₹36 Cr	₹58 Cr	₹57 Cr	₹71 Cr	₹81 Cr	₹78 Cr	₹76 Cr
₹329 Cr	₹278 Cr	₹225 Cr	₹203 Cr	₹171 Cr	₹164 Cr	₹149 Cr	₹136 Cr	₹130 Cr	₹143 Cr	₹159 Cr	₹154 Cr	₹156 Cr	₹153 Cr	₹156 Cr	₹137 Cr	₹123 Cr	₹123 Cr	₹134 Cr	₹147 Cr	₹142 Cr	₹135 Cr
₹38	₹33	₹64	₹57	₹51	₹44	₹39	₹37	₹34	₹39	₹35	₹33	₹33	₹33	₹33	₹30	₹28	₹25	₹23	₹22	₹21	₹20
₹38	₹33	₹26	₹23	₹20	₹17	₹16	₹15	₹14	₹16	₹14	₹13	₹13	₹13	₹13	₹12	₹11	₹10	₹9	₹9	₹8	₹8

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
₹58 Cr	₹70 Cr	₹30 Cr	₹35 Cr	₹27 Cr	₹22 Cr	₹9 Cr	₹9 Cr	-₹12 Cr	₹14 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹10 Cr	₹9 Cr	₹11 Cr	₹10 Cr	₹5 Cr	₹5 Cr
₹4 Cr	-₹12 Cr	₹8 Cr	₹10 Cr	-₹1 Cr	-₹2 Cr	-₹57 L	₹33 L	₹1 Cr	-₹9 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹8 Cr	₹7 Cr
-₹2 Cr	₹5 Cr	₹6 Cr	₹9 Cr	-₹11 Cr	₹12 Cr	₹5 Cr	₹20 Cr	₹9 Cr	-₹6 Cr	-₹2 Cr	-₹4 Cr	-₹3 Cr	₹3 Cr	-₹8 Cr	-₹7 Cr	-₹9 Cr	₹11 Cr	₹1 Cr	-₹2 Cr
₹59 Cr	₹63 Cr	₹44 Cr	₹54 Cr	₹14 Cr	₹31 Cr	₹14 Cr	₹29 Cr	-₹2 Cr	-₹36 L	₹10 Cr	₹5 Cr	₹8 Cr	₹13 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹27 Cr	₹14 Cr	₹10 Cr
₹47 Cr	₹55 Cr	₹35 Cr	₹47 Cr	₹7 Cr	₹28 Cr	₹12 Cr	₹31 Cr	-₹2 Cr	-₹3 Cr	₹9 Cr	₹4 Cr	₹8 Cr	₹12 Cr	₹7 Cr	₹5 Cr	₹86 L	₹18 Cr	₹6 Cr	₹2 Cr
-₹36 Cr	-₹45 Cr	-₹25 Cr	-₹58 Cr	-₹26 Cr	-₹2 Cr	-₹11 Cr	-₹83 L	-₹3 Cr	₹41 Cr	-₹2 Cr	-₹46 L	-₹1 Cr	-₹3 Cr	-₹5 Cr	-₹7 Cr	-₹2 Cr	-₹8 Cr	-₹5 Cr	-₹9 Cr
-₹12 Cr	-₹12 Cr	-₹9 Cr	-₹46 L	-₹18 Cr	-₹7 Cr	-₹2 Cr	-₹6 Cr	-₹60 L	-₹34 Cr	-₹6 Cr	-₹1 Cr	-₹4 Cr	-₹8 Cr	₹41 L	₹3 Cr	₹1 Cr	-₹10 Cr	-₹84 L	₹7 Cr
-₹99 L	-₹2 Cr	₹2 Cr	-₹11 Cr	-₹36 Cr	₹19 Cr	-₹1 Cr	₹24 Cr	-₹6 Cr	₹5 Cr	₹52 L	₹2 Cr	₹2 Cr	₹46 L	₹3 Cr	₹2 Cr	₹3 L	-₹40 L	₹3 L	₹18 L
₹11 Cr	₹13 Cr	₹11 Cr	₹23 Cr	₹59 Cr	₹40 Cr	₹41 Cr	₹15 Cr	₹20 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹7 Cr	₹6 Cr	₹18 L	₹58 L	₹55 L	₹38 L
₹10 Cr	₹11 Cr	₹13 Cr	₹11 Cr	₹23 Cr	₹59 Cr	₹40 Cr	₹39 Cr	₹15 Cr	₹20 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹7 Cr	₹21 L	₹18 L	₹58 L	₹55 L

Fundamental Ratios

Consolidated

Standalone

No results found

Jagsonpal Pharmaceuticals Share Price

216.21-0.12 (-0.06%)

-2.98% past 1 Year

Shareholding summary

Promoters

68.81%

FII

2.13%

DII

1.64%

Others

27.42%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
68.81%	69.05%	67.89%	67.39%	67.54%	67.65%
2.13%	2.30%	2.44%	2.12%	2.12%	2.17%
1.64%	0.62%	0.22%	0.15%	0.08%	0.05%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
27.42%	28.03%	29.45%	30.34%	30.26%	30.13%

Bulk & block deals

Name

Blitzquant Research Llp

Nk Securities Research Private Limited

Blitzquant Research Llp

Microcurves Trading Private Limited

Silverleaf Capital Services Private Limited

Blitzquant Research Llp

Microcurves Trading Private Limited

Nk Securities Research Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
24 Sep 2026	Purchase	8.05 Cr	₹242.60	3.32 L	Bulk	0.503311	NSE
24 Sep 2026	Purchase	10.22 Cr	₹241.03	4.24 L	Bulk	0.642642	NSE
24 Sep 2026	Sell	10.22 Cr	₹241.20	4.24 L	Bulk	0.642642	NSE
24 Sep 2026	Sell	8.06 Cr	₹242.74	3.32 L	Bulk	0.503311	NSE
30 Jul 2026	Sell	8.38 Cr	₹254.43	3.29 L	Bulk	0.499312	NSE
30 Jul 2026	Sell	14.87 Cr	₹252	5.90 L	Bulk	0.894798	NSE
30 Jul 2026	Purchase	10.33 Cr	₹250.43	4.12 L	Bulk	0.62545	NSE
30 Jul 2026	Purchase	8.37 Cr	₹254.30	3.29 L	Bulk	0.499312	NSE
30 Jul 2026	Purchase	14.86 Cr	₹251.82	5.90 L	Bulk	0.894798	NSE
30 Jul 2026	Purchase	15.19 Cr	₹249.74	6.08 L	Bulk	0.922472	NSE

Insider trading & SAST

Client name

Infinity Holdings & Others

Infinity Portfolio Holdings

Infinity Portfolio Holdings & Pacs

Infinity Portfolio Holdings

Nfinity Holdings & Pacs

Aresko Progressive Pvt Ltd

Rajpal Singh Kochhar (For And On Behalf Of Aresko Progressive Private Limited Acting In Capacity As A Trustee Of The Aresko Progressive Trust; And As The Representative Partner Of J&P Investments Partnership)

Jasbir Kaur Kochhar

Rajpal Singh Kochhar

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
20 Sep 2024	Promoter	Disposal	8.6	43.3	0	—	22.87 L	13 Sep 2024	Market	1,14,55,500	SAST	29(2)	—
20 Sep 2024	Promoter	Acquisition	8.6	—	0	—	22.87 L	01 Jan 1900	—	—	SAST	10(5)	—
20 Sep 2024	Promoter	Acquisition	8.6	43.3	0	—	22.87 L	13 Sep 2024	Market	1,14,55,500	SAST	29(1)	—
20 Sep 2024	Other	Acquisition	8.6	—	0	—	22.87 L	13 Sep 2024	-	—	SAST	10(6)	—
30 Jun 2022	Promoter	Acquisition	43.72	43.72	0	—	1.15 Cr	27 Jun 2022	Off Market	1,14,55,500	SAST	29(1)	—
30 Jun 2022	Promoter	Disposal	43.73	20.36	0	—	1.15 Cr	27 Jun 2022	Off Market	53,34,254	SAST	29(2)	—
29 Jun 2022	Promoter Group	Disposal	43.72662	20.36	269.20 Cr	₹235	1.15 Cr	27 Jun 2022	Off Market	53,34,254	Insider Trading	—	Equity Shares
21 Apr 2022	Promoter	Acquisition	22.79	31.74	0	—	59.71 L	11 Sep 2014	Transmission	83,16,176	SAST	29(2)	—
21 Apr 2022	Promoter	Acquisition	3.38	32.55	0	—	8.86 L	08 Aug 2014	Gift	85,27,464	SAST	29(2)	—
20 Apr 2022	Promoter	Acquisition	0.58	34.91	0	—	1.53 L	21 Dec 2015	Gift	91,45,064	SAST	29(2)	—

Jagsonpal Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Jagsonpal Pharmaceuticals Share Price

Jagsonpal Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Jagsonpal Pharmaceuticals Share Price

Jagsonpal Pharmaceuticals Share Price

Oscillators

Moving averages

Jagsonpal Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Jagsonpal Pharmaceuticals Share Price

Corporate Actions

Company details

Jagsonpal Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Jagsonpal Pharmaceuticals Share Price

News

Jagsonpal Pharmaceuticals Reports Stable Q2 EBITDA With Lower Operating Margin

Jagsonpal Pharmaceuticals Reports Flat Q2 Net Profit Year On Year

Jagsonpal Pharmaceuticals Reports Stronger Second Quarter Revenue Growth

Jagsonpal Pharmaceuticals Acquires Wellness Segment Through Slump Sale

Jagsonpal Pharma Q1 EBITDA rises year-on-year with margin expansion

Jagsonpal Pharma Q1 revenue rises year on year, driven by core operations

Jagsonpal Pharma posts higher Q1 standalone net profit year on year

Jagsonpal Pharma acquires majority stake in Aequitas Healthcare, makes it subsidiary

Jagsonpal Pharma to acquire 85 percent stake in Aequitas Healthcare

Jagsonpal Pharmaceuticals to acquire 85 percent stake in Aequitas Healthcare

Jagsonpal Pharmaceuticals informs about allotment of equity shares under ESOP

Jagsonpal Pharmaceuticals Board Recommends Dividend of Rs 4 Per Equity Share.

Jagsonpal Pharma Reports Strong Q4 EBITDA Growth of 27.6% YoY to Rs 11.10 Crores.

Jagsonpal Pharma Q4 FY Results: Net Profit Up 33% YoY to Rs 8.80 Crores, Revenue Rises 10% to Rs 64.20 Crores.

Jagsonpal Pharma reports Profit after tax of 8.76 Crores, in the March 2026 quarter

Jagsonpal Pharmaceuticals submits voting results of postal ballot

Jagsonpal Pharmaceuticals informs about press release

Jagsonpal Pharmaceuticals informs about board meeting

Jagsonpal Pharmaceuticals Board Approves Buyback of 16 Lakh Shares at Rs 250 Each via Tender Route.

Jagsonpal Pharmaceuticals informs about allotment of equity shares

Jagsonpal Pharmaceuticals Ltd Share Price Today

Jagsonpal Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator